Out of 336 initial submissions across both Business and NPO Tracks, DiaTheris is the winner of Switzerland's leading early-stage startups...

https://www.unige.ch/medecine/phym/en/home/an-innosuisse-grant-for-a-game-changing-diabetes-treatment/ Type 1 diabetes is a disease in...

Diatheris will be presented at the Swiss Accelerators' Showcase taking place the 28 November 2022. Meet the founders in the virtual 3D...

DIATHERIS has been awarded the Innovation Trophy 2022. The "Diatheris" project, which is developing an approach aimed at overcoming the...

Unrestrained ketogenesis leads to life-threatening ketoacidosis whose incidence is high in patients with diabetes. While insulin therapy...